26 April 2017

Prof Glenn Gibson - Friends in Low Places: Getting to the Guts of Microbiology

Organised by:

SCI's Membership Affairs Committee

SCI, London, UK

Registration Closed

This event is no longer available for registration.

It is now well-known that certain bacteria in the human gut have a positive impact on health and there is an entire industry devoted to foods and supplements that are believed to exert a functional effect on human gut microbiota, promoting better health. However, it is a complex and often controversial topic with both probiotics and prebiotics being advocated.

Day 1 - 26 April 2017

Lecture Schedule
Lecture starts
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact


14/15 Belgrave Square

SCI Comms Team

Tel: +44 (0) 20 7598 1594

Email: communications@soci.org

Additional Info

Join SCI for its Public Evening Lecture series which are free and open to all. 

Approaches to Microbiology
Health and wellbeing is a key area where applied science has clear societal benefits, particularly in terms of nutrition. Glenn Gibson, Professor of Food Microbiology at the University of Reading, is widely regarded as the UK's leading expert in this field.
On Wednesday 26 April 2017, at SCI's Public Evening Lecture, Professor Gibson will compare and contrast differing approaches to microbiology, providing data on the use of both probiotics and prebiotics in humans and their impact on health.

About the Speaker
Prof Gibson was at the forefront of developing early thinking on prebiotics, instigating the concept in a 1995 paper. Since then, he has continued to lead the field of human gut bacteriology, sitting on 5 advisory panels and publishing more than 400 research articles, 10 patents, and 8 books on the topic.
He is the former President of the International Scientific Association for Probiotics and Prebiotics and has led more than 120 research projects, as well as supervising 65 PhD students.
He is currently carrying out specific projects on probiotics and prebiotics, the molecular genotyping of gut bacteria, H2S production, as well as gastroenteritis in sportspersons, metabolic syndrome, IBS, IBD, and gut flora development with age and colonic homeostasis.

This event will be recorded and posted on the SCI website. Please note: some members of the audience may be in view during the question and answer session at the end of the lecture